CD8A and plasma cell myeloma: Xu et al. have shown that in models of murine multiple myeloma, ALT-803 therapy induced expansion of memory CD8+ T cells with upregulated NKG2D expression and increased secretion of IFN-γ; in addition, the effect of ALT-803 was shown to be independent of antigen-specific stimulation [45].